Physician profile
Asad Mohmand
NPI 1336349182
$3,105.17
in general payments reported to CMS, 2019-2025
22 companies · $94.05 in 2025
The $94.05 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,027 · 2020: $281 · 2021: $1,205 · 2023: $473 · 2024: $25.24 · 2025: $94.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $429 · Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $428.66 |
| Food and Beverage | $163.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $428.66 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $392.72 | 2019-2021 | |
| Viiv Healthcare Company | $390.69 | 2019-2021 | |
| Gilead Sciences, INC. | $346.12 | 2019-2021 | |
| Janssen Biotech, INC. | $296.17 | 2019-2021 | |
| Melinta Therapeutics, LLC | $258.44 | 2019-2021 | |
| Abbvie INC. | $197.49 | 2019-2023 | |
| Cumberland Pharmaceuticals, INC. | $161.70 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $153.20 | 2019-2021 | |
| Insmed, INC. | $108.35 | 2019 | |
| Imperative Care, INC | $68.90 | 2025 | Symphony Catheter |
| Allergan, INC. | $66.09 | 2019-2020 | |
| Astellas Pharma US INC | $39.95 | 2021 | |
| Shionogi INC | $29.80 | 2021 | |
| Theratechnologies INC. | $26.60 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $25.24 | 2024 | Thinprep 2000 Processor, Aptima |
| Stryker Corporation | $25.15 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Dynavax Technologies Corporation | $21.35 | 2019 | |
| Shire North American Group INC | $18.81 | 2019 | |
| Genentech USA, INC. | $17.85 | 2021 | |
| W. L. Gore & Associates, INC. | $17.03 | 2019 | |
| Napo Pharmaceuticals INC | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Mohmand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.